- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-5960
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Models of α-synuclein aggregation in Parkinson’s disease ; volume:2 ; number:1 ; day:13 ; month:12 ; year:2014 ; pages:1-17 ; date:12.2014
Acta Neuropathologica Communications ; 2, Heft 1 (13.12.2014), 1-17, 12.2014
- Creator
-
Giráldez-Pérez, Rosa María
- Contributor
-
Antolín-Vallespín, Mónica
Muñoz, María Dolores
Sánchez-Capelo, Amelia
SpringerLink (Online service)
- DOI
-
10.1186/s40478-014-0176-9
- URN
-
urn:nbn:de:1111-201608026435
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Giráldez-Pérez, Rosa María
- Antolín-Vallespín, Mónica
- Muñoz, María Dolores
- Sánchez-Capelo, Amelia
- SpringerLink (Online service)
Other Objects (12)
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Structure and dynamics of the aggregation mechanism of the Parkinson's disease-associated protein α-synuclein [alpha-synuclein]
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson’s disease mouse model
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Structure and dynamics of the aggregation mechanism of the Parkinson's disease-associated protein α-synuclein [alpha-synuclein]
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease
Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson’s disease mouse model
Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease
Dermal α-synuclein oligomers and aggregates in Parkinson’s disease
Role of Apolipoproteins and α-Synuclein in Parkinson’s Disease
Phosphorylated α-synuclein in Parkinson’s disease: correlation depends on disease severity
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
Initiation and progression of α-synuclein pathology in Parkinson’s disease
Structure and dynamics of the aggregation mechanism of the Parkinson's disease-associated protein α-synuclein [alpha-synuclein]
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Retinal α-synuclein deposits in Parkinson’s disease patients and animal models
Association of Glial Activation and α-Synuclein Pathology in Parkinson’s Disease
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease